Companies /Technology

Cognizant Technology Solutions Corp - Class A

NASDAQ: CTSH Information Technology Services
$63.76
â–² $1.67 (+2.69%) today
Markets closed · 5:03am ET

Q3 2025 Earnings

Reported Oct 29, 2025, 6:32am ET · SEC source
$1.39
Beat +6.73%
EPS · est. $1.30
$5.4B
Beat +1.83%
Revenue · est. $5.3B
+9.1%
Beating market
CTSH vs S&P since report
1 quarter
Consecutive EPS misses

Market Reaction

% change · around the report
−10%−5%0+5%Oct 29Oct 30report 6:32am ETearnings−0.7%+1.5%
−10%−5%0+5%Oct 29Oct 30earnings−0.7%+1.5%
CTSH +1.5%S&P 500 −0.7%
−10%−5%0+5%Oct 29Oct 30report 6:32am ETearnings−0.8%+1.5%
−10%−5%0+5%Oct 29Oct 30earnings−0.8%+1.5%
CTSH +1.5%NASDAQ −0.8%
−5%0+5%Oct 28Nov 5report 6:32am ETearnings−1.5%+5.2%
−5%0+5%Oct 28Nov 5earnings−1.5%+5.2%
CTSH +5.2%S&P 500 −1.5%
−5%0+5%Oct 28Nov 5report 6:32am ETearnings−1.9%+5.2%
−5%0+5%Oct 28Nov 5earnings−1.9%+5.2%
CTSH +5.2%NASDAQ −1.9%
+5.71%
Day of report
+0.70%
Next session
+4.14%
One week
+8.01%
30 days

S&P 500 over the same 30 days: −1.04%.

Did CTSH Beat Earnings? Q3 2025 Results

Cognizant delivered a convincing third quarter, with adjusted diluted EPS of $1.39 beating the $1.30 consensus estimate by 6.73% and revenue of $5.42 billion clearing expectations by 1.83% on 7.4% year-over-year growth, as the company marked its fifth consecutive quarter of organic revenue expansion. The quarter's standout driver was broad-based demand momentum, anchored by the Belcan acquisition contributing roughly 250 basis points to growth and six large deals signed with total contract values exceeding $100 million each, bringing year-to-date TCV growth to 40%. GAAP results were clouded by a $390 million non-cash tax charge tied to the One Big Beautiful Bill Act's repeal of R&E cost capitalization requirements, pulling GAAP diluted EPS to $0.56 from $1.17 a year ago, though adjusted figures reflected genuine underlying progress. The strong performance prompted management to raise full-year 2025 constant currency revenue growth guidance to 6.0%-6.3%, with full-year adjusted EPS now expected in the $5.22-$5.26 range, a signal of growing confidence in the company's AI-driven digital transformation pipeline at a time when peers are similarly lifting their outlooks.

Key Takeaways
  • Fifth consecutive quarter of year-over-year organic revenue growth
  • Strongest sequential organic growth since 2022
  • North America drove geographic outperformance with 7.8% growth
  • Broad-based growth across all segments and geographies
  • Belcan acquisition contributed approximately 250 basis points to YoY revenue growth
  • Six large deals signed in Q3 (TCV $100M+), bringing YTD total to 16 with 40% TCV growth
  • Strong cost discipline drove 70 basis points of YoY Adjusted Operating Margin expansion
  • Trailing 12-month bookings of $27.5 billion, up 5% YoY with 1.3x book-to-bill

“Third quarter revenue grew 6.5% year-over-year and 2.8% sequentially in constant currency, representing our fifth consecutive quarter of year-over-year organic revenue growth and our strongest sequential organic growth since 2022.”

Cognizant CEO, on the earnings call

Forward Guidance & Outlook

Cognizant raised its full-year 2025 guidance. Q4 2025 revenue is expected at $5.27-$5.33 billion (3.8%-4.8% YoY growth, or 2.5%-3.5% in constant currency). Full-year 2025 revenue is expected at $21.05-$21.10 billion (6.6%-6.9% YoY growth, or 6.0%-6.3% in constant currency), above prior guidance. Full-year 2025 Adjusted Operating Margin is expected at approximately 15.7%, representing 40 basis points of expansion and the high end of prior guidance. Full-year 2025 Adjusted Diluted EPS is expected in the range of $5.22-$5.26. The company expects an Adjusted effective tax rate of 24%-25% and approximately 489 million diluted shares. Cognizant is on track to return $2.0 billion to shareholders in 2025.

CTSH YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$2.0B$4.0B$5.0B$5.4BRevenue$1.7B$1.8BGross Profit$738.0M$866.0MOperating Income$582.0M$274.0MNet Income
$0$2.0B$4.0BRevenueGross ProfitOperating IncomeNet Income

CTSH Revenue by Segment

Financial Services$1.6B+6.2%
Health Sciences$1.6B+5.9%
Products and Resources$1.4B+12.6%
Communications, Media and Technology$850.0M+4.2%

CTSH Revenue by Geography

North America$4.0B+7.8%
Europe$1.0B+7.8%
United Kingdom$503.0M+4.4%
Rest of World$345.0M+0.9%

Figures from SEC filings and company reports. Not investment advice.